318 related articles for article (PubMed ID: 22122637)
1. Cancer stem cell epigenetics and chemoresistance.
Crea F; Danesi R; Farrar WL
Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
[TBL] [Abstract][Full Text] [Related]
2. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
3. Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells.
Xu M; Gong A; Yang H; George SK; Jiao Z; Huang H; Jiang X; Zhang Y
Cancer Lett; 2015 Dec; 369(1):124-33. PubMed ID: 26276718
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell pathways and chemotherapy response: an unexplored route.
Duhagon MA; Crea F; Danesi R; Farrar WL
Ann Oncol; 2013 Feb; 24(2):558-559. PubMed ID: 23233652
[No Abstract] [Full Text] [Related]
5. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
6. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
[TBL] [Abstract][Full Text] [Related]
7. Targeting embryonic signaling pathways in cancer therapy.
Harris PJ; Speranza G; Dansky Ullmann C
Expert Opin Ther Targets; 2012 Jan; 16(1):131-45. PubMed ID: 22239436
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Bourguignon LY; Shiina M; Li JJ
Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
[TBL] [Abstract][Full Text] [Related]
9. ABCG2: the key to chemoresistance in cancer stem cells?
An Y; Ongkeko WM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic modulation in cancer stem cell fate.
Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
[TBL] [Abstract][Full Text] [Related]
13. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
Takebe N; Harris PJ; Warren RQ; Ivy SP
Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
Marquardt JU; Factor VM; Thorgeirsson SS
J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
[TBL] [Abstract][Full Text] [Related]
18. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
Siddique HR; Saleem M
Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high/CD44high prostate cancer stem cells.
Acikgoz E; Mukhtarova G; Alpay A; Avci CB; Bagca BG; Oktem G
Mol Biol Rep; 2021 Apr; 48(4):3567-3578. PubMed ID: 33948856
[TBL] [Abstract][Full Text] [Related]
20. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]